A Phase 1 Dose Escalation Study of Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor PRT543 in Patients With Myeloid Malignancies

Manish R. Patel, Varun Monga, Shekeab Jauhari, Don Ambrose Stevens, Lucia Masarova, Meredith McKean, David Mauro, John Viscusi, Peggy Scherle, Neha Bhagwat, Andrew Moore, William Sun, Rachel Chiaverelli, Eric Mintah, Rajneesh Nath, Eytan Stein, Neil Palmisiano, Grerk Sutamtewagul, Srdan Verstovsek. 63rd ASH Annual Meeting and Exposition; December 11-14, 2021.